Literature DB >> 7741165

Is fever a good sign for clinical malaria in surveys of endemic communities?

T Smith1, N Hurt, T Teuscher, M Tanner.   

Abstract

Although fever is the characteristic sign of clinical malaria, many Plasmodium falciparum malaria cases in endemic areas do not present with measurable temperature elevations. In a field study in Tanzania, malaria morbidity was defined to be any current self- or parentally reported illness associated with malaria parasite densities higher than those in healthy individuals. Without diagnosis of individual episodes, prevalences of malaria-attributable morbidity of 9.8% in infants, 1.3% in children 1-4 years of age, and 0.6% in those 5-9 years of age were estimated. No illness was considered to be due to malaria in older individuals. In infants, 66.5% of malaria-attributable morbidity episodes corresponded to axillary temperatures < 37.5 degrees C. In older children, most of the episodes due to malaria corresponded to increased temperatures. This age dependence should be considered when designing diagnostic procedures and outcome measures for epidemiologic studies of malaria.

Entities:  

Mesh:

Year:  1995        PMID: 7741165     DOI: 10.4269/ajtmh.1995.52.306

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Estimating the number of paediatric fevers associated with malaria infection presenting to Africa's public health sector in 2007.

Authors:  Peter W Gething; Viola C Kirui; Victor A Alegana; Emelda A Okiro; Abdisalan M Noor; Robert W Snow
Journal:  PLoS Med       Date:  2010-07-06       Impact factor: 11.069

2.  Estimating the global clinical burden of Plasmodium falciparum malaria in 2007.

Authors:  Simon I Hay; Emelda A Okiro; Peter W Gething; Anand P Patil; Andrew J Tatem; Carlos A Guerra; Robert W Snow
Journal:  PLoS Med       Date:  2010-06-15       Impact factor: 11.069

3.  Association of HIV-Induced Immunosuppression and Clinical Malaria in Nigerian Adults.

Authors:  Michael O Iroezindu; Emmanuel I Agaba; Comfort A Daniyam; Edith N Okeke; Oche O Agbaji; Patricia A Agaba; Godwin E Imade; John A Idoko
Journal:  Afr J Infect Dis       Date:  2012

Review 4.  A research agenda for malaria eradication: diagnoses and diagnostics.

Authors: 
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

5.  Asymptomatic falciparum malaria and intestinal helminths co-infection among school children in Osogbo, Nigeria.

Authors:  Olusola Ojurongbe; Adebola M Adegbayi; Oloyede S Bolaji; Akeem A Akindele; Olusegun A Adefioye; Oluwaseyi A Adeyeba
Journal:  J Res Med Sci       Date:  2011-05       Impact factor: 1.852

6.  Malaria infection and disease in an area with pyrethroid-resistant vectors in southern Benin.

Authors:  Georgia B Damien; Armel Djènontin; Christophe Rogier; Vincent Corbel; Sahabi B Bangana; Fabrice Chandre; Martin Akogbéto; Dorothée Kindé-Gazard; Achille Massougbodji; Marie-Claire Henry
Journal:  Malar J       Date:  2010-12-31       Impact factor: 2.979

7.  Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda.

Authors:  Richard Ndyomugyenyi; Pascal Magnussen; Siân Clarke
Journal:  Malar J       Date:  2007-04-02       Impact factor: 2.979

8.  A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.

Authors:  Philip Bejon; Jedidah Mwacharo; Oscar Kai; Tabitha Mwangi; Paul Milligan; Stephen Todryk; Sheila Keating; Trudie Lang; Brett Lowe; Caroline Gikonyo; Catherine Molyneux; Greg Fegan; Sarah C Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
Journal:  PLoS Clin Trials       Date:  2006-10-20

9.  Measures of clinical malaria in field trials of interventions against Plasmodium falciparum.

Authors:  Thomas A Smith
Journal:  Malar J       Date:  2007-05-02       Impact factor: 2.979

10.  Malaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern Tanzania.

Authors:  John P A Lusingu; Lasse S Vestergaard; Bruno P Mmbando; Chris J Drakeley; Caroline Jones; Juma Akida; Zacharia X Savaeli; Andrew Y Kitua; Martha M Lemnge; Thor G Theander
Journal:  Malar J       Date:  2004-07-28       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.